The Effect of E-EPA on Circulating LDL and Plasma Lipid Metabolism

NCT04152291 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

68

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis
Low-density Lipoproteins Aggregation Susceptibility
Low-density Lipoprotein Lipid Composition
Cardiovascular Diseases

Interventions

DIETARY_SUPPLEMENT: Ethyl-Eicosapentaenoic Acid (E-EPA)

Sponsor

Wihuri Research Institute

Collaborators

[object Object]